Interferon-gamma prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion.

The significant function of cytokines includes maintenance of cell survival as well as induction of cell differentiation and/or proliferation. We demonstrate here that interferon-gamma (IFN-gamma) plays a role for progression of Epstein-Barr virus (EBV)-infected natural killer cell leukemia (NK leukemia) through maintaining cell survival. NK leukemia cells obtained from 7 patients had clonal episomal forms of EBV, indicating that the leukemic cells were of clonal origin. Although normal NK cells constitutively expressed Bcl-2, the EBV-infected NK leukemia cells lacked endogenous Bcl-2 expression and were hypersensitive to apoptosis in vitro. The addition of IFN-gamma to the culture significantly inhibited their spontaneous apoptosis without inducing cell proliferation or upregulation of Bcl-2. The NK leukemia cells constitutively secreted IFN-gamma, and the patients' sera contained a high concentration of IFN-gamma, levels that were high enough to prevent NK leukemia cells from apoptosis. Bcl-XL was not involved in the IFN-gamma-induced NK leukemia cell survival. These data suggest that the acquisition of IFN-gamma-mediated autocrine survival signals, other than Bcl-2 or BCL-XL, might be important for the development of EBV-infected NK leukemia.

[1]  I. Weissman,et al.  Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.

[2]  B. Bonavida,et al.  Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells. , 1997, Journal of immunology.

[3]  H. Cantor,et al.  A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. , 1997, Immunity.

[4]  J. Chen,et al.  Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. , 1997, The Journal of clinical investigation.

[5]  M. Jäättelä,et al.  The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type , 1997, Journal of virology.

[6]  G. Trinchieri,et al.  Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. , 1997, Journal of immunology.

[7]  J. Sample,et al.  Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma , 1997, Journal of virology.

[8]  I. Weissman,et al.  Enforced Expression of Bcl-2 in Monocytes Rescues Macrophages and Partially Reverses Osteopetrosis in op/op Mice , 1997, Cell.

[9]  I. Weissman,et al.  Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient Mice , 1997, Cell.

[10]  Y. Hsu,et al.  Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Masahiko Kato,et al.  Haemophagocytic lymphohistiocytosis in association with granular lymphocyte proliferative disorders in early childhood: characteristic bone marrow morphology , 1997, British journal of haematology.

[12]  C. Croce,et al.  A potential role for interleukin-15 in the regulation of human natural killer cell survival. , 1997, The Journal of clinical investigation.

[13]  M. Caligiuri,et al.  Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. , 1997, Blood.

[14]  H. Kanegane,et al.  Virus-cell interactions in a natural killer-like cell line from a patient with lymphoblastic lymphoma. , 1996, Blood.

[15]  J. Zhang,et al.  The AML1/ETO fusion protein activates transcription of BCL-2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Sklar,et al.  Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia. , 1996, International journal of hematology.

[17]  W. Wilmanns,et al.  Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. , 1996, Leukemia.

[18]  A. Levine,et al.  Expression of Epstein‐Barr virus nuclear antigen‐1 induces B cell neoplasia in transgenic mice. , 1996, The EMBO journal.

[19]  E. Jaffe.  Classification of natural killer (NK) cell and NK-like T-cell malignancies. , 1996, Blood.

[20]  M. Caligiuri,et al.  Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. , 1995, The Journal of clinical investigation.

[21]  A. Galy,et al.  Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. , 1995, Immunity.

[22]  S. Mori,et al.  Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein‐Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells , 1995, British journal of haematology.

[23]  C. Meijer,et al.  Expression of bcl‐2 protein and transcription of the Epstein‐Barr virus bcl‐2 homologue BHRF‐1 in Hodgkin's disease: implications for different pathogenic mechanisms , 1995, Histopathology.

[24]  S. Hibi,et al.  Haemophagocytic lymphohistiocytosis, interferon‐gamma‐naemia and Epstein‐Barr virus involvement , 1994, British journal of haematology.

[25]  A. Tefferi,et al.  Chronic natural killer cell lymphocytosis: a descriptive clinical study. , 1994, Blood.

[26]  M. Caligiuri,et al.  The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Akashi,et al.  Involvement of interferon‐γ and macrophage colony‐stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults , 1994, British journal of haematology.

[28]  C. Gregory,et al.  Apoptosis in Burkitt lymphoma cells is driven by c-myc. , 1993, Oncogene.

[29]  T. M. Dexter,et al.  Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors , 1993, Cell.

[30]  H. Kawaguchi,et al.  Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. , 1993, The Journal of clinical investigation.

[31]  T. Loughran,et al.  Clonal diseases of large granular lymphocytes. , 1993, Blood.

[32]  S. Asano,et al.  Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. , 1993, Leukemia.

[33]  D. Campana,et al.  Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia , 1993, The Journal of experimental medicine.

[34]  D. Shibata,et al.  Description of an In Situ Hybridization Methodology for Detection of Epstein‐Barr Virus RNA in Paraffin‐Embedded Tissues, with a Survey of Normal and Neoplastic Tissues , 1992, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[35]  C. Gregory,et al.  Prevention of programmed cell death in burkitt lymphoma cell lines by bcl‐2‐dependent and ‐independent mechanisms , 1992, International journal of cancer.

[36]  M. Rowe,et al.  Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. , 1992, Blood.

[37]  U. Andersson,et al.  Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. , 1991, Blood.

[38]  K. Akashi,et al.  Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34- blasts from acute myelogenous leukemia. , 1991, Blood.

[39]  E. Kieff,et al.  Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.

[40]  A. Öst,et al.  DIAGNOSTIC GUIDELINES FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS , 1991 .

[41]  R. Schreiber,et al.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.

[42]  M. Rowe,et al.  Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein , 1990, Journal of virology.

[43]  H. Dohy,et al.  Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature POSSIBLE EXISTENCE OF A NEW CLINICAL ENTITY ORIGINATING FROM THE THIRD LINEAGE OF LYMPHOID CELLS , 1990, British journal of haematology.

[44]  W. Hammerschmidt,et al.  Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes , 1989, Nature.

[45]  K. Hirai,et al.  CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. , 1989, The Journal of clinical investigation.

[46]  Gwyn T. Williams,et al.  Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures , 1989, Nature.

[47]  N. Raab-Traub,et al.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation , 1986, Cell.

[48]  Robert Walgate,et al.  Proliferation , 1985, Nature.

[49]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[50]  G. Klein,et al.  Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx , 1970, Nature.

[51]  M. Matsuoka,et al.  Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus. , 1995, Blood.

[52]  K. Akashi,et al.  Hepatosinusoidal leukaemia/lymphoma consisting of epstein‐barr virus‐containing natural killer cell leukaemia/lymphoma and T‐cell lymphoma; mimicking malignant histiocytosis , 1995, Hematological oncology.

[53]  J. Rouault,et al.  Effects of BCL-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells. , 1994, Blood.

[54]  A. Tefferi,et al.  Chronic natural killer cell lymphocytosis: a descriptive clinical study. , 1994, Blood.

[55]  P. Mcsweeney,et al.  Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes. , 1993, Blood.

[56]  A. Ost,et al.  Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. , 1991, Seminars in oncology.